India vs Nepal: Treatment success rate for patients treated for MDR-TB
India
77.0%
in 2022
Nepal
77.0%
in 2022
India rank
61st
Nepal rank
61st
Treatment success rate for patients treated for MDR-TB over time
- India
- Nepal
How they compare
India currently reports 77.0% against 77.0% in Nepal, a difference of 0.0%.
Across all 16 years both countries report, Nepal has been ahead every year.
India ranks 61st and Nepal ranks 61st of 163 countries.
Nepal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.7% | 69.7% | 21.0% | Nepal |
| 2010s | 49.2% | 72.0% | 22.8% | Nepal |
| 2020s | 73.0% | 76.3% | 3.3% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, India or Nepal?
- India, at 77.0% against 77.0% in Nepal as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between India and Nepal?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and Nepal?
- 16 years are reported by both, from 2007 to 2022.
- How do India and Nepal rank globally for treatment success rate for patients treated for mdr-tb?
- India ranks 61st and Nepal ranks 61st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.